October 1976

Intravenous Nutrition in the High Risk Infant

Author Affiliations

College of Physicians and Surgeons Columbia University 630 W 168th St New York, NY 10032

Am J Dis Child. 1976;130(10):1165. doi:10.1001/archpedi.1976.02120110127028

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Sir.—I am writing to respond to the review by Dr Hossein Ghadimi (Am J Dis Child 130:340, 1976) of the book entitled Intravenous Nutrition in the High Risk Infant, edited by Dr Eileen Hasselmeyer and me.

In addition to the accepted roles of scientific critic and proofreader, with which I have no quarrel, Dr Ghadimi has assumed the role of pundit in making allegations that cannot be substantiated from the contents of our book.

Thus he states that "Dr Winters remains the staunch defender of the Food and Drug Administration (FDA) and pharmaceutical companies." Evidence to justify the intent of this sentence is nowhere apparent in the book. In fact, the only place where the FDA or the pharmaceutical industry is even mentioned occurs on page 247 in an open discussion following a formal paper by Dr Halvor Christensen. In his paper (page 240), Dr Christensen suggested, "Some means

First Page Preview View Large
First page PDF preview
First page PDF preview